ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

Funding opportunities listed.

October 15, 2004

Memantine Can Delay Onset Of Cognitive Function Decline

November 30, 2012

NCAB Review Of Cancer Control Program Finds It Has Made Substantial Progress But Has Problems

October 13, 1978

Some Children With Hodgkin’s Disease Can Reduce Or Skip Radiation, Study Finds

October 29, 2004

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

NCI Advisory Group, Other Cancer Meetings For September, October

August 27, 1976